363 related articles for article (PubMed ID: 10564593)
1. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
[TBL] [Abstract][Full Text] [Related]
2. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
[TBL] [Abstract][Full Text] [Related]
3. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).
Litman T; Brangi M; Hudson E; Fetsch P; Abati A; Ross DD; Miyake K; Resau JH; Bates SE
J Cell Sci; 2000 Jun; 113 ( Pt 11)():2011-21. PubMed ID: 10806112
[TBL] [Abstract][Full Text] [Related]
4. Chromosome mediated gene transfer of drug resistance to mitoxantrone.
Hazlehurst LA; Gros P; Dalton WS
Anticancer Res; 1998; 18(2A):1005-10. PubMed ID: 9615755
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
Nieuwint AW; Baas F; Wiegant J; Joenje H
Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
[TBL] [Abstract][Full Text] [Related]
6. Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in glioblastoma.
Kubota H; Nishizaki T; Harada K; Harada K; Oga A; Ito H; Suzuki M; Sasaki K
Genes Chromosomes Cancer; 2001 Jun; 31(2):125-33. PubMed ID: 11319800
[TBL] [Abstract][Full Text] [Related]
7. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.
Slovak ML; Ho JP; Cole SP; Deeley RG; Greenberger L; de Vries EG; Broxterman HJ; Scheffer GL; Scheper RJ
Cancer Res; 1995 Oct; 55(19):4214-9. PubMed ID: 7671223
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization.
Nielsen KV; Niebuhr E; Ejlertsen B; Holstebroe S; Madsen MW; Briand P; Mouridsen HT; Bolund L
Genes Chromosomes Cancer; 1997 Sep; 20(1):30-7. PubMed ID: 9290951
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
10. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in chemoresistant variants of three cell lines of different origin.
Johnsson A; Vallon-Christensson J; Strand C; Litman T; Eriksen J
Anticancer Res; 2005; 25(4):2661-8. PubMed ID: 16080509
[TBL] [Abstract][Full Text] [Related]
13. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.
Fairchild CR; Ivy SP; Kao-Shan CS; Whang-Peng J; Rosen N; Israel MA; Melera PW; Cowan KH; Goldsmith ME
Cancer Res; 1987 Oct; 47(19):5141-8. PubMed ID: 2441861
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells.
Matsui S; LaDuca J; Rossi MR; Nowak NJ; Cowell JK
Cancer Genet Cytogenet; 2005 May; 159(1):18-26. PubMed ID: 15860352
[TBL] [Abstract][Full Text] [Related]
16. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
17. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
[TBL] [Abstract][Full Text] [Related]
18. Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas.
Tonon G; Gehlhaus KS; Yonescu R; Kaye FJ; Kirsch IR
Cancer Genet Cytogenet; 2004 Jul; 152(1):15-22. PubMed ID: 15193437
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cells.
Biedler JL; Chang TD; Scotto KW; Melera PW; Spengler BA
Cancer Res; 1988 Jun; 48(11):3179-87. PubMed ID: 3365701
[TBL] [Abstract][Full Text] [Related]
20. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]